Skip to main content
Boule Diagnostics logo

Boule Diagnostics — Investor Relations & Filings

Ticker · BOUL ISIN · SE0011231158 LEI · 213800IK1TGY858TKZ45 ST Manufacturing
Open in API
Filings indexed 223 across all filing types
Latest filing 2018-02-21 Major Shareholding Noti…
Country SE Sweden
Listing ST BOUL

About Boule Diagnostics

https://boule.com/

Boule Diagnostics is a global provider of diagnostic solutions specializing in hematology. The company develops, manufactures, and markets systems and consumables for blood diagnostics, including hematology analyzers, clinical chemistry analyzers, and associated reagents, controls, and calibrators. Its products are tailored for decentralized healthcare settings in both the human and veterinary markets, such as smaller laboratories and clinics. The company aims to enhance global healthcare access by providing high-quality instruments that deliver timely and accurate blood test results.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2018
Major Shareholding Notification Classification · 1% confidence The document explicitly details a change in shareholding for 'Swedbank Robur Fonder AB' in 'Boule Diagnostic AB'. It specifies the 'Before the transaction' and 'After the transaction' share quantities, the resulting percentage (10.23%), and the 'Reason for major shareholding notification Buy'. This structure perfectly matches the definition of a Major Shareholding Notification, which is categorized under the code MRQ.
2018-02-21 English
Earnings Release 2017
Earnings Release Classification · 1% confidence The document is titled "Bokslutskommuniké januari–december 2017" (Year-end report January–December 2017) and contains detailed financial figures for the fourth quarter and the full year (January–December 2017), including Net Sales, Operating Result (EBIT), Cash Flow, Balance Sheet items, and management commentary. This structure is characteristic of a comprehensive annual financial report, which aligns with the definition of a 10-K (Annual Report), even though the specific filing format might be a local equivalent (like a year-end report in Sweden). Since the document provides the full annual performance review, it is classified as an Annual Report. FY 2017
2018-02-16 Swedish
Boule Diagnostics – Antal aktier och röster
Share Issue/Capital Change Classification · 1% confidence The document discusses changes in the total number of shares and votes in the company due to the exercise of options from incentive programs. It explicitly states the total number of shares after the issuance and mentions that the information is being made public according to financial instrument trading laws. This content directly relates to changes in the company's capital structure (shares outstanding). Therefore, the most appropriate classification is 'Share Issue/Capital Change' (SHA). It is not a general earnings release (ER), a full annual report (10-K), or a dividend notice (DIV).
2017-12-29 Swedish
Boule Diagnostics utser ny direktör med ansvar för Commercial Operations
Board/Management Information Classification · 1% confidence The document announces the appointment of a new director, Kiarash Farr, to the management group, replacing Claes Blanche. This directly relates to changes in senior management personnel. According to the definitions, 'Board/Management Information' (Code: MANG) covers the 'Announcement of changes in the company's board of directors or senior management.' The text is a formal announcement regarding executive personnel changes, making MANG the most appropriate classification.
2017-12-01 Swedish
Boule Diagnostics – Antal aktier och röster
Share Issue/Capital Change Classification · 1% confidence The document details changes in the total number of shares and votes in the company due to the exercise of stock options from incentive programs. It explicitly states the number of new shares issued and the resulting total share count as of November 30, 2017. This directly relates to changes in the company's capital structure and share count. The filing concludes by stating the information is required to be made public according to financial instrument trading laws, suggesting a mandatory disclosure. This fits best under 'Share Issue/Capital Change' (SHA), as it reports the issuance of new shares resulting from option exercises, which alters the share capital base.
2017-11-30 Swedish
Major Shareholding Notification 2017
Major Shareholding Notification Classification · 1% confidence The document details a change in shareholding for 'Linc AB' in 'Boule Diagnostic AB', specifically noting a 'Sell' transaction and providing the 'Before' and 'After' share quantities and resulting voting rights percentages (0.6%). The structure, focusing on instrument details, transaction reasons, and resulting distribution of total holdings, is characteristic of a notification regarding significant ownership changes. This aligns directly with the definition for Major Shareholding Notification (MRQ). The document length is short (3933 chars), but the content is the notification itself, not an announcement of a report.
2017-11-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.